Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Milnacipran hydrochloride

Milnacipran hydrochloride

pharmaceutical raw materials
Milnacipran hydrochloride structure

Milnacipran hydrochloride 

structure
  • CAS No:

    101152-94-7

  • Formula:

    C15H22N2O.ClH

  • Chemical Name:

    Milnacipran hydrochloride

  • Synonyms:

    Cyclopropanecarboxamide,2-(aminomethyl)-N,N-diethyl-1-phenyl-,hydrochloride (1:1),(1R,2S)-rel-;Cyclopropanecarboxamide,2-(aminomethyl)-N,N-diethyl-1-phenyl-,monohydrochloride,cis-(±)-;Cyclopropanecarboxamide,2-(aminomethyl)-N,N-diethyl-1-phenyl-,monohydrochloride,(1R,2S)-rel-;F 2207;Milnacipran hydrochloride;Cyclopropanecarboxamide,2-(aminomethyl)-N,N-diethyl-1-phenyl-,monohydrochloride,cis-;Ixel;Dalcipran;Toledomin;Savella;Tivanyl;Joncia;86181-08-0

  • Categories:

    Analytical Chemistry  >  Standard

Description

Crystalline Solid


Levomilnacipran is a serotonin and norepinephrine reuptake inhibitor used to treat major depressive disorders. Levomilnacipran is an enantiomer of milnacipran, which is used to treat fibromyalgia. Levomilnacipran and milnacipran have been associated with a low rate of transient elevations in serum aminotransferase levels during treatment and with rare instances of clinically apparent acute liver injury with jaundice.|A cyclopropanecarboxamide serotonin and norepinephrine reuptake inhibitor (SNRI) that is used in the treatment of FIBROMYALGIA.

Milnacipran hydrochloride Basic Attributes

282.81

282.149902

200-659-6

759806

DTXSID4046785

29242990

Characteristics

48 Ų

white solid

181-189 °C

421.5°C at 760 mmHg

9℃

H2O: 19 mg/mL

2-8°C

LD50 orally in mice: 237 mg/kg (Bonnaud)

Safety Information

III

6.1

UN 2811 6.1/PG 3

3

22-39/23/24/25-23/24/25-11

7-16-36/37-45

GZ1014010

Xn,T,F

P301 + P310

H301

|Danger|H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]|P264, P270, P301+P310, P321, P330, P405, and P501|Aggregated GHS information provided by 49 companies from 5 notifications to the ECHA C&L Inventory.

Toxicity

In large clinical trials, elevations in serum aminotransferase levels during levomilnacipran and milnacipran therapy occurred in 7% of patients, but were usually mild and self-limited. Elevations above 5 times the upper limit of normal (ULN) occurred in ~1% of patients and generally resolved, even without dose adjustment or discontinuation. There has been a single published report of clinically apparent liver injury with jaundice attributed to milnacipran therapy, with a mixed pattern of liver enzyme elevations, transient increases in bilirubin without jaundice, immunoallergic features and rapid recovery on stopping (Case 1).

Drug Information

Levomilnacipran is a serotonin and norepinephrine reuptake inhibitor used to treat major depressive disorders. Levomilnacipran is an enantiomer of milnacipran, which is used to treat fibromyalgia. Levomilnacipran and milnacipran have been associated with a low rate of transient elevations in serum aminotransferase levels during treatment and with rare instances of clinically apparent acute liver injury with jaundice.

Antidepressants

A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)|Drugs that selectively block or suppress the plasma membrane transport of SEROTONIN and NORADRENALINE into axon terminals and are used as ANTIDEPRESSIVE AGENTS. (See all compounds classified as Serotonin and Noradrenaline Reuptake Inhibitors.)

1 Phenyl 1 diethylaminocarbonyl 2 aminomethylcyclopropane HCl

Milnacipran hydrochloride Use and Manufacturing

Uses

antibacterial

Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients

Computed Properties

Molecular Weight:282.81
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:2
Rotatable Bond Count:5
Exact Mass:282.1498911
Monoisotopic Mass:282.1498911
Topological Polar Surface Area:46.3
Heavy Atom Count:19
Complexity:295
Undefined Atom Stereocenter Count:2
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Drug Function and Efficacy

No specific mention from the above information

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • Luzhou Kereide Pharmaceutical Co., Ltd.

    China China
    Active
  • CENTAUR PHARMACEUTICALS PVT LTD

    United States United States
    Active
  • LUPIN MANUFACTURING SOLUTIONS LTD

    United States United States
    Active

Recommended Suppliers of Milnacipran hydrochloride

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.